Company intelligence / Profile preview

Bristol Investment Fund

Princeton, New Jersey, United States

Ownership: Private
Employees: ~34100
Development stage: Other

Overview

Bristol Myers Squibb commercializes over 280 drugs, including major products like Opdivo and Reblozyl, with significant clinical results and frequent regulatory milestones. The company's portfolio includes marketed drugs in oncology, hematology, immunology, cardiovascular, and neuroscience.

Therapeutic areas: ImmunologyEndocrinologyRheumatologyPsychiatryInfectious DiseasesHematologyCardiovascularOncologyNeurology
Modalities: Small moleculeMonoclonal antibodyBiologic
Industry: Pharma

Partnerships

Joint ventures and co-development with third parties for specific drugs

Beyond the preview

Go deeper on Bristol Investment Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bristol Investment Fund.

Explore the full profile